🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
18,156
Companies
1,062
Drugs tracked
3,187

Quick answer

NovaPharmaNews tracks 18,156 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

1,425 results for “Elan” Clear

  1. Bortezomib STADA 2,5 mg/ml Injektionslösung, Dexamethason 0,5 mg JENAPHARM®, Empliciti 400 mg powder for concentrate for solution for infusion., Kyprolis 60 mg powder for solution for infusion, Privigen 100 mg/ml solution for infusion, Privigen 100 mg/ml solution for infusion, Imnovid 1 mg hard capsules, -, Nodexon 20 mg tabletes, Imnovid 3 mg hard capsules, Imnovid 4 mg hard capsules, Imnovid 2 mg hard capsules, Nodexon 20 mg tabletės, ELRANATAMAB, Dexamethason 4 mg JENAPHARM®

    Pfizer Ireland Pharmaceuticals Unlimited Company

    Relapsed/Refractory Multiple Myeloma

    phase 3 small molecule active

    1 trial

  2. Brincidofovir

    Jazz Pharmaceuticals Ireland Limited

    Adenovirus Infection

    phase 3 small molecule completed

    1 trial

  3. Brincidofovir

    Jazz Pharmaceuticals Ireland Limited

    CMV

    phase 3 small molecule completed

    1 trial

  4. Brincidofovir

    Jazz Pharmaceuticals Ireland Limited

    Double-stranded DNA Virus

    phase 3 small molecule completed

    1 trial

  5. Brincidofovir

    Jazz Pharmaceuticals Ireland Limited

    Cytomegalovirus Disease

    phase 3 small molecule terminated

    2 trials

  6. Bupivacaine

    Pacira Ireland Limited

    Malignant Neoplasms of Female Genital Organs

    phase 3 small molecule terminated

    1 trial

  7. Bupivacaine HCl

    Pacira Ireland Limited

    Hemorrhoids

    phase 3 small molecule completed

    1 trial

  8. Bupivacaine HCl

    Pacira Ireland Limited

    Postoperative Pain

    phase 3 small molecule completed

    3 trials

  9. Bupivacaine liposome

    Pacira Ireland Limited

    Dental Pain

    phase 3 small molecule completed

    1 trial

  10. Bupivacaine liposome injectable suspension 266 mg

    Pacira Ireland Limited

    Bunionectomy

    phase 3 small molecule completed

    1 trial

  11. CALCIUM FOLINATE, IRINOTECAN HYDROCHLORIDE TRIHYDRATE, BEVACIZUMAB, BEVACIZUMAB, PANITUMUMAB, SOTORASIB, FLUOROURACIL

    Amgen Technology (Ireland) UC

    Colorectal Cancer (CRC)

    phase 3 small molecule active

    1 trial

  12. CAPECITABINE, Fluorouracil 50 mg/ml Solution for Injection or Infusion, Oxaliplatin 5mg/ml concentrate for solution for infusion, CETUXIMAB, ENCORAFENIB, Calcium Folinate 10 mg/ml Injection, CAMPTO 20 mg/mL concentrate for solution for infusion, Irinotecan hydrochloride 20 mg/ml concentrate for solution for infusion, CAMPTO 20 mg/mL concentrate for solution for infusion, FLUOROURACIL, IRINOTECAN, Bevacizumab, CALCIUM FOLINATE, Capecitabine, Cetuximab, OXALIPLATIN, Oxaliplatin 5mg/ml concentrate for Solution

    Pfizer Ireland Pharmaceuticals Unlimited Company

    Colorectal cancer (BRAF V600E-mutant mCRC)

    phase 3 small molecule active

    1 trial

  13. CISPLATIN

    Cancer Prevention Pharma (Ireland) Limited

    Ovarian epithelial cancer : intraperitoneal resectable relapse

    phase 3 small molecule active

    1 trial

  14. CMP-001

    Regeneron UK Limited

    Melanoma

    phase 3 small molecule completed

    3 trials

  15. CPX-351

    Jazz Pharmaceuticals Ireland Limited

    High Risk Acute Myeloid Leukemia

    phase 3 small molecule completed

    1 trial

  16. CTX001

    Vertex Pharmaceuticals (Ireland) Limited

    Beta-Thalassemia

    phase 3 mab active

    1 trial

  17. CYCLOPHOSPHAMIDE, Myocet liposomal 50 mg powder, dispersion and solvent for concentrate for dispersion for infusion., DOXORUBICIN, DOCETAXEL

    Cancer Prevention Pharma (Ireland) Limited

    oestrogen-receptor (ER)-positive HER2-negative breast carcinoma

    phase 3 small molecule active

    1 trial

  18. Calcium carbonate

    Arrowhead Pharmaceuticals Ireland Limited

    Uterine Contraction

    phase 3 small molecule completed

    1 trial

  19. Cannabidiol (CBD)

    Jazz Pharmaceuticals Ireland Limited

    Clinical High Risk for Psychosis (CHR)

    phase 3 small molecule active

    1 trial

  20. Capecitabine Accord 150 mg film-coated tablets, Fluorouracil 25 mg/ml Solution for Injection or Infusion, Irinotecan Accord 20 mg/ml Solution à diluer pour perfusion, OXALIPLATINE ARROW LAB 5 mg/mL, solution à diluer pour perfusion, Leucovorin-Teva 10 mg/ml Concentrate for Solution for Infusion

    Cancer Prevention Pharma (Ireland) Limited

    Stage III colorectal cancer

    phase 3 small molecule active

    1 trial

  21. Capsule to match PF-06651600 (Ritlecitinib) 50 mg, Ritlecitinib tosilate, DEXAMETHASONE, Capsule to match pf-06651600 (ritlecitinib) 100 mg, Ritlecitinib Tosilate

    Pfizer Ireland Pharmaceuticals Unlimited Company

    NON SEGMENTAL VITILIGO

    phase 3 small molecule active

    1 trial

  22. Casgevy 4 - 13 x 10^6 cells/mL dispersion for infusion

    Vertex Pharmaceuticals (Ireland) Limited

    Sickle Cell Disease, Transfusion dependent thalassemia

    phase 3 small molecule active

    1 trial

  23. Casgevy 4 - 13 x 10^6 cells/mL dispersion for infusion, BUSULFAN, FILGRASTIM, PLERIXAFOR

    Vertex Pharmaceuticals (Ireland) Limited

    Transfusion-Dependent-Thalassemia

    phase 3 small molecule active

    1 trial

  24. Casgevy 4 - 13 x 10^6 cells/mL dispersion for infusion, BUSULFAN, FILGRASTIM, PLERIXAFOR

    Vertex Pharmaceuticals (Ireland) Limited

    Transfusion-dependent β-thalassemia (TDT)

    phase 3 small molecule active

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 18,156 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources